Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Presenter: Meir Shinnar

November 05, 2021

REGISTER for free or LOG IN to view this content

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Heart Failure

TCT 2021

Up Next

Presentation TCT 2021

Left Atrial Appendage Interventions – Closing the Key Evidence Gaps to Move the Field Forward, From FDA Perspective

Presenter: Kan Fang

November 05, 2021

More slides +

Presentation TCT 2021

Digital Health Apps in Cardiovascular Device Trials, a Clinician's Perspective

Presenter: Mintu Turakhia

November 05, 2021

Presentation TCT 2021

Digital Health Apps in Cardiovascular Device Trials, From FDA Perspective

Presenter: George Van Hare

November 05, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.